Rising costs, constrained spending and wider economic uncertainty pushed hundreds of businesses into insolvency in 2025, ...
Iovance Biotherapeutics targets significant market expansion, with lung cancer representing a $10B U.S. peak sales ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback